VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Pathogen Page
Equid herpesvirus

Table of Contents

  1. General Information
    1. NCBI Taxonomy ID
    2. Disease
    3. Introduction
    4. Microbial Pathogenesis
    5. Host Ranges and Animal Models
  2. Vaccine Related Pathogen Genes
    1. gE
    2. gI
    3. TK
  3. Vaccine Information
    1. Encephalomyelitis-Rhinopneumonitis Eastern & Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4844.30)
    2. Encephalomyelitis-Rhinopneumonitis-Influenza Eastern & Western & Venezuelan, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4847.22)
    3. Encephalomyelitis-Rhinopneumonitis-Influenza Eastern & Western & Venezuelan, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4847.23)
    4. Encephalomyelitis-Rhinopneumonitis-Influenza Eastern & Western & Venezuelan, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4847.24)
    5. Encephalomyelitis-Rhinopneumonitis-Influenza Eastern & Western & Venezuelan, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4847.32)
    6. Encephalomyelitis-Rhinopneumonitis-Influenza Eastern & Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4845.23)
    7. Encephalomyelitis-Rhinopneumonitis-Influenza Eastern & Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4845.24)
    8. Encephalomyelitis-Rhinopneumonitis-Influenza Eastern & Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4845.32)
    9. Encephalomyelitis-Rhinopneumonitis-Influenza Eastern & Western, Killed Virus Vaccine-Tetanus Toxoid (USDA: 4845.33)
    10. Encephalomyelitis-Rhinopneumonitis-Influenza-West Nile Virus Eastern & Western, Killed Virus, Killed Flavivirus Chimera Vaccine-Tetanus Toxoid (USDA: 4855.R2)
    11. Equid herpesvirus gE mutant vaccine
    12. Equid herpesvirus gI mutant vaccine
    13. Equid herpesvirus TK mutant vaccine
    14. Equine Rhinopneumonitis Killed Virus Vaccine (USDA: 1525.20)
    15. Equine Rhinopneumonitis Killed Virus Vaccine (USDA: 1525.21)
    16. Equine Rhinopneumonitis Killed Virus Vaccine (USDA: 1525.22)
    17. Equine Rhinopneumonitis Killed Virus Vaccine (USDA: 1525.24)
    18. Equine Rhinopneumonitis Modified Live Virus Vaccine (USDA: 1521.20)
    19. Equine Rhinopneumonitis-Influenza Killed Virus Vaccine (USDA: 1515.24)
    20. Equine Rhinopneumonitis-Influenza Killed Virus Vaccine (USDA: 1515.26)
    21. Equine Rhinopneumonitis-Influenza Killed Virus Vaccine (USDA: 1515.27)
    22. Equine Rhinopneumonitis-Influenza Killed Virus Vaccine (USDA: 1515.2A)
    23. Equine Rhinopneumonitis-Influenza Modified Live & Killed Virus Vaccine (USDA: 1518.20)
    24. NYVAC-EHV-1- vP1014
  4. References
I. General Information
1. NCBI Taxonomy ID:
10326
2. Disease:
Equine Rhinopneumonitis
3. Introduction
In equids eight herpesviruses have been identified: five belong to the subfamily alpha herpesvirinae and three to the gamma herpesvirinae. The horse is the natural host to alphaherpesvirus types 1 (EHV-1), 3 (EHV-3 coital exanthemavirus), 4 (EHV-4) and gammaherpesvirus types 2 (EHV-2) and 5 (EHV-5). Until 1981, EHV-1 and EHV-4 were considered as two subtypes of the same virus, namely EHV-1. Both EHV-1 and EHV-4 are endemic in horse populations worldwide. Prior to 1981, a single virus ‘EHV-1’ was known as the cause of febrile rhinopneumonitis, ataxia, abortions and neonatal foal disease in horses (Allen and Bryans, 1986). However, it should be stated that as early as 1972 most ‘EHV-1’ strains were distinguishable as respiratory (subtype 2) and abortigenic (subtype 1) viruses. Acute, naturally occurring respiratory diseases due to EHV-1 and EHV-4 are characterised by fever, anorexia, nasal discharge of varying severity and ocular discharge. Bacterial proliferation in nasal passages may be a contributory factor in the development of rhinopneumonitis. Experimentally, however, EHV-1 causes a much more severe disease than that induced by EHV-4 (Patel and Heldens, 2005).
4. Microbial Pathogenesis
Primary EHV-1 replication occurs in the upper respiratory tract epithelial cells and local lymph nodes resulting in leukocyte-associated viremia. Leukocyte associated viremia in acute infection has been shown as a prerequisite for abortion and paresis by initiating replication of EHV-1 in the endothelial lining of blood vessels in the central nervous system (CNS) and pregnant uterus. A widespread infection of endometrial blood vessels results in severe vasculitis and multifocal thrombosis, which could result in an abortion of a virus negative fetus. Latency has been demonstrated in lymphoid and neural tissues for both EHV-1 and EHV-4 (Patel and Heldens, 2005).
5. Host Ranges and Animal Models
Equids
Loading...
Loading Pathogen Genes...
Loading...
Loading Host Genes...
Loading...
Loading Vaccines...
Loading References...